This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Zanshun Zheng: Innovator in Anti-VEGF Antibody Development
Introduction
Zanshun Zheng is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target vascular endothelial growth factor (VEGF). His work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Zanshun Zheng holds 1 patent for his invention related to Anti-VEGF antibodies. This patent focuses on antibodies that specifically bind to VEGF, emphasizing heavy-chain antibodies and single-domain antibodies. The invention also includes methods for producing these antibodies and their therapeutic applications.
Career Highlights
Zanshun Zheng is associated with Zhuhai Essex Bio-Pharmaceutical Co., Ltd., where he applies his expertise in antibody development. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements in medical treatments.
Collaborations
Zanshun Zheng has collaborated with notable colleagues, including Haizhou Fang and Wei Qu. These partnerships enhance the research and development efforts within his field, fostering innovation and progress.
Conclusion
Zanshun Zheng's contributions to the development of Anti-VEGF antibodies highlight his role as an influential inventor in biotechnology. His work not only advances scientific knowledge but also has the potential to improve therapeutic outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile